晚期乳腺癌的治疗与生存情况
Treatment and survival on advanced breast cancer.
作者信息
Priestman T, Baum M, Jones V, Forbes J
出版信息
Br Med J. 1978 Dec 16;2(6153):1673-4. doi: 10.1136/bmj.2.6153.1673.
Abstract
The final results of a clinical trial comparing endocrine with cytotoxic drug treatment for advanced breast cancer were analysed. Although cytotoxic treatment gave a significantly higher response rate with a remission duration comparable to that obtained with endocrine treatment, the sequence in which the two treatments were given did not appear to influence survival--except possibly in women with rapidly progressing disease, when cytotoxic treatment is preferred.
摘要
对一项比较内分泌治疗与细胞毒性药物治疗晚期乳腺癌的临床试验的最终结果进行了分析。尽管细胞毒性治疗的缓解率显著更高，缓解持续时间与内分泌治疗相当，但两种治疗的给药顺序似乎并未影响生存率——可能快速进展性疾病的女性除外，这类患者首选细胞毒性治疗。
相似文献
1
Treatment and survival on advanced breast cancer.晚期乳腺癌的治疗与生存情况
Br Med J. 1978 Dec 16;2(6153):1673-4. doi: 10.1136/bmj.2.6153.1673.
2
Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer.晚期乳腺癌内分泌治疗与细胞毒性治疗的对比试验。
Br Med J. 1977 May 14;1(6071):1248-50. doi: 10.1136/bmj.1.6071.1248.
3
Trends in chemotherapy of breast cancer.乳腺癌化疗的趋势
Prog Clin Biol Res. 1977;12:425-36.
4
Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer.雌激素受体与晚期乳腺癌内分泌治疗及细胞毒性化疗反应
Cancer. 1980 Dec 15;46(12 Suppl):2922-4. doi: 10.1002/1097-0142(19801215)46:12+<2922::aid-cncr2820461435>3.0.co;2-d.
5
Management of breast cancer.乳腺癌的管理
Clin Pharm. 1982 Nov-Dec;1(6):515-29.
6
[Study of long-term survivors after treatment of thoracic metastases from breast cancer by hormone therapy and nonhormonal antineoplastic chemotherapy combined from the onset].[乳腺癌胸壁转移起始即联合激素治疗与非激素抗肿瘤化疗后的长期生存者研究]
Rev Tuberc Pneumol (Paris). 1972 Apr-May;36(3):460-4.
7
Efforts to combine endocrine and chemotherapy in the management of breast cancer: do two and two equal three?
Breast Cancer Res Treat. 1983;3(2):117-27. doi: 10.1007/BF01803554.
8
9
Therapy of advanced breast cancer; a review.
Eur J Cancer Clin Oncol. 1983 Dec;19(12):1775-8. doi: 10.1016/0277-5379(83)90166-9.
10
Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: report of the Swiss Group for Clinical Cancer Research.晚期乳腺癌中细胞毒性化疗与激素治疗的同步或序贯使用：瑞士临床癌症研究组报告
Br Med J (Clin Res Ed). 1983 Jan 1;286(6358):5-8. doi: 10.1136/bmj.286.6358.5.
引用本文的文献
1
Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer.转移性乳腺癌单纯化疗与单纯内分泌治疗的比较
Cochrane Database Syst Rev. 2003;2003(2):CD002747. doi: 10.1002/14651858.CD002747.
2
Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer.多柔比星每周给药联合5-氟尿嘧啶持续输注治疗晚期乳腺癌。
Br J Cancer. 1996 Dec;74(12):2008-12. doi: 10.1038/bjc.1996.668.
3
Effect of chemotherapy on survival in metastatic breast cancer.化疗对转移性乳腺癌患者生存的影响。
Breast Cancer Res Treat. 1981;1(4):357-63. doi: 10.1007/BF01806751.
4
Prospects for the future in the management of carcinoma of the breast: the biological fall out from clinical trials.乳腺癌管理的未来前景：临床试验带来的生物学影响
Br J Cancer. 1984 Feb;49(2):117-22. doi: 10.1038/bjc.1984.22.
5
Quality of life after cytotoxic chemotherapy: discussion paper.细胞毒性化疗后的生活质量：讨论文件。
J R Soc Med. 1984 Jun;77(6):492-5. doi: 10.1177/014107688407700610.
6
Does chemotherapy improve survival in advanced breast cancer? A statistical overview.化疗能提高晚期乳腺癌患者的生存率吗？统计综述。
Br J Cancer. 1988 Jun;57(6):615-8. doi: 10.1038/bjc.1988.140.
本文引用的文献
1
Therapeutic significance of sex-steroid hormone receptors in the treatment of breast cancer.性甾体激素受体在乳腺癌治疗中的治疗意义。
Eur J Cancer (1965). 1977 Nov;13(11):1205-15. doi: 10.1016/0014-2964(77)90026-3.
2
Comparative trial of endocrine versus cytotoxic treatment in advanced breast cancer.晚期乳腺癌内分泌治疗与细胞毒性治疗的对比试验。
Br Med J. 1977 May 14;1(6071):1248-50. doi: 10.1136/bmj.1.6071.1248.
Zotero 插件